Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 19 of 19 entries
Sorted by: Best Match Show Resources per page
Tau Phosphorylation by GSK3 in Different Conditions.

International journal of Alzheimer's disease

Avila J, León-Espinosa G, García E, García-Escudero V, Hernández F, Defelipe J.
PMID: 22675648
Int J Alzheimers Dis. 2012;2012:578373. doi: 10.1155/2012/578373. Epub 2012 May 17.

Almost a 20% of the residues of tau protein are phosphorylatable amino acids: serine, threonine, and tyrosine. In this paper we comment on the consequences for tau of being a phosphoprotein. We will focus on serine/threonine phosphorylation. It will...

Cite
Avila J, León-Espinosa G, García E, et al. Tau Phosphorylation by GSK3 in Different Conditions. Int J Alzheimers Dis. 2012;2012:578373doi: 10.1155/2012/578373.
Avila, J., León-Espinosa, G., García, E., García-Escudero, V., Hernández, F., & Defelipe, J. (2012). Tau Phosphorylation by GSK3 in Different Conditions. International journal of Alzheimer's disease, 2012578373. https://doi.org/10.1155/2012/578373
Avila, Jesús, et al. "Tau Phosphorylation by GSK3 in Different Conditions." International journal of Alzheimer's disease vol. 2012 (2012): 578373. doi: https://doi.org/10.1155/2012/578373
Avila J, León-Espinosa G, García E, García-Escudero V, Hernández F, Defelipe J. Tau Phosphorylation by GSK3 in Different Conditions. Int J Alzheimers Dis. 2012;2012:578373. doi: 10.1155/2012/578373. Epub 2012 May 17. PMID: 22675648; PMCID: PMC3362846.
Copy Download .nbib Format: NLM
Prostaglandin F.

Neoplasia (New York, N.Y.)

Jiménez-Segovia A, Mota A, Rojo-Sebastián A, Barrocal B, Rynne-Vidal A, García-Bermejo ML, Gómez-Bris R, Hawinkels LJAC, Sandoval P, Garcia-Escudero R, López-Cabrera M, Moreno-Bueno G, Fresno M, Stamatakis K.
PMID: 31734628
Neoplasia. 2019 Nov;21(11):1073-1084. doi: 10.1016/j.neo.2019.10.001. Epub 2019 Nov 14.

The role of prostaglandin (PG) F

Cite
Jiménez-Segovia A, Mota A, Rojo-Sebastián A, et al. Prostaglandin F. Neoplasia. 2019;21(11):1073-1084doi: 10.1016/j.neo.2019.10.001.
Jiménez-Segovia, A., Mota, A., Rojo-Sebastián, A., Barrocal, B., Rynne-Vidal, A., García-Bermejo, M. L., Gómez-Bris, R., Hawinkels, L. J. A. C., Sandoval, P., Garcia-Escudero, R., López-Cabrera, M., Moreno-Bueno, G., Fresno, M., & Stamatakis, K. (2019). Prostaglandin F. Neoplasia (New York, N.Y.), 21(11), 1073-1084. https://doi.org/10.1016/j.neo.2019.10.001
Jiménez-Segovia, Alba, et al. "Prostaglandin F." Neoplasia (New York, N.Y.) vol. 21,11 (2019): 1073-1084. doi: https://doi.org/10.1016/j.neo.2019.10.001
Jiménez-Segovia A, Mota A, Rojo-Sebastián A, Barrocal B, Rynne-Vidal A, García-Bermejo ML, Gómez-Bris R, Hawinkels LJAC, Sandoval P, Garcia-Escudero R, López-Cabrera M, Moreno-Bueno G, Fresno M, Stamatakis K. Prostaglandin F. Neoplasia. 2019 Nov;21(11):1073-1084. doi: 10.1016/j.neo.2019.10.001. Epub 2019 Nov 14. PMID: 31734628; PMCID: PMC6888713.
Copy Download .nbib Format: NLM
Modulating Effect of Diet on Alzheimer's Disease.

Diseases (Basel, Switzerland)

Fernández-Sanz P, Ruiz-Gabarre D, García-Escudero V.
PMID: 30691140
Diseases. 2019 Jan 26;7(1). doi: 10.3390/diseases7010012.

As life expectancy is growing, neurodegenerative disorders, such as Alzheimer's disease, are increasing. This disease is characterised by the accumulation of intracellular neurofibrillary tangles formed by hyperphosphorylated tau protein, senile plaques composed of an extracellular deposit of β-amyloid peptide...

Cite
Fernández-Sanz P, Ruiz-Gabarre D, García-Escudero V. Modulating Effect of Diet on Alzheimer's Disease. Diseases. 2019;7(1)doi: 10.3390/diseases7010012.
Fernández-Sanz, P., Ruiz-Gabarre, D., & García-Escudero, V. (2019). Modulating Effect of Diet on Alzheimer's Disease. Diseases (Basel, Switzerland), 7(1), . https://doi.org/10.3390/diseases7010012
Fernández-Sanz, Paloma, et al. "Modulating Effect of Diet on Alzheimer's Disease." Diseases (Basel, Switzerland) vol. 7,1 (2019). doi: https://doi.org/10.3390/diseases7010012
Fernández-Sanz P, Ruiz-Gabarre D, García-Escudero V. Modulating Effect of Diet on Alzheimer's Disease. Diseases. 2019 Jan 26;7(1). doi: 10.3390/diseases7010012. PMID: 30691140; PMCID: PMC6473547.
Copy Download .nbib Format: NLM
p38 Inhibition Decreases Tau Toxicity in Microglia and Improves Their Phagocytic Function.

Molecular neurobiology

Perea JR, Bolós M, Cuadros R, García E, García-Escudero V, Hernández F, McManus RM, Heneka MT, Avila J.
PMID: 35006531
Mol Neurobiol. 2022 Jan 10; doi: 10.1007/s12035-021-02715-0. Epub 2022 Jan 10.

Alzheimer's disease (AD) and other tauopathies are histopathologically characterized by tau aggregation, along with a chronic inflammatory response driven by microglia. Over the past few years, the role of microglia in AD has been studied mainly in relation to...

Cite
Perea JR, Bolós M, Cuadros R, et al. p38 Inhibition Decreases Tau Toxicity in Microglia and Improves Their Phagocytic Function. Mol Neurobiol. 2022;doi: 10.1007/s12035-021-02715-0.
Perea, J. R., Bolós, M., Cuadros, R., García, E., García-Escudero, V., Hernández, F., McManus, R. M., Heneka, M. T., & Avila, J. (2022). p38 Inhibition Decreases Tau Toxicity in Microglia and Improves Their Phagocytic Function. Molecular neurobiology, . https://doi.org/10.1007/s12035-021-02715-0
Perea, Juan R, et al. "p38 Inhibition Decreases Tau Toxicity in Microglia and Improves Their Phagocytic Function." Molecular neurobiology vol. (2022). doi: https://doi.org/10.1007/s12035-021-02715-0
Perea JR, Bolós M, Cuadros R, García E, García-Escudero V, Hernández F, McManus RM, Heneka MT, Avila J. p38 Inhibition Decreases Tau Toxicity in Microglia and Improves Their Phagocytic Function. Mol Neurobiol. 2022 Jan 10; doi: 10.1007/s12035-021-02715-0. Epub 2022 Jan 10. PMID: 35006531.
Copy Download .nbib Format: NLM
Correction: The soluble pattern recognition receptor PTX3 links humoral innate and adaptive immune responses by helping marginal zone B cells.

The Journal of experimental medicine

Chorny A, Casas-Recasens S, Sintes J, Shan M, Polentarutti N, García-Escudero R, Walland AC, Yeiser JR, Cassis L, Carrillo J, Puga I, Cunha C, Bastos H, Rodrigues F, Lacerda JF, Morais A, Dieguez-Gonzalez R, Heeger PS, Salvatori G, Carvalho A, Garcia-Sastre A, Blander JM, Mantovani A, Garlanda C, Cerutti A.
PMID: 28420735
J Exp Med. 2017 May 01;214(5):1559. doi: 10.1084/jem.2015028204172017c. Epub 2017 Apr 18.

No abstract available.

Cite
Chorny A, Casas-Recasens S, Sintes J, et al. Correction: The soluble pattern recognition receptor PTX3 links humoral innate and adaptive immune responses by helping marginal zone B cells. J Exp Med. 2017;214(5):1559doi: 10.1084/jem.2015028204172017c.
Chorny, A., Casas-Recasens, S., Sintes, J., Shan, M., Polentarutti, N., García-Escudero, R., Walland, A. C., Yeiser, J. R., Cassis, L., Carrillo, J., Puga, I., Cunha, C., Bastos, H., Rodrigues, F., Lacerda, J. F., Morais, A., Dieguez-Gonzalez, R., Heeger, P. S., Salvatori, G., Carvalho, A., Garcia-Sastre, A., Blander, J. M., Mantovani, A., Garlanda, C., & Cerutti, A. (2017). Correction: The soluble pattern recognition receptor PTX3 links humoral innate and adaptive immune responses by helping marginal zone B cells. The Journal of experimental medicine, 214(5), 1559. https://doi.org/10.1084/jem.2015028204172017c
Chorny, Alejo, et al. "Correction: The soluble pattern recognition receptor PTX3 links humoral innate and adaptive immune responses by helping marginal zone B cells." The Journal of experimental medicine vol. 214,5 (2017): 1559. doi: https://doi.org/10.1084/jem.2015028204172017c
Chorny A, Casas-Recasens S, Sintes J, Shan M, Polentarutti N, García-Escudero R, Walland AC, Yeiser JR, Cassis L, Carrillo J, Puga I, Cunha C, Bastos H, Rodrigues F, Lacerda JF, Morais A, Dieguez-Gonzalez R, Heeger PS, Salvatori G, Carvalho A, Garcia-Sastre A, Blander JM, Mantovani A, Garlanda C, Cerutti A. Correction: The soluble pattern recognition receptor PTX3 links humoral innate and adaptive immune responses by helping marginal zone B cells. J Exp Med. 2017 May 01;214(5):1559. doi: 10.1084/jem.2015028204172017c. Epub 2017 Apr 18. PMID: 28420735; PMCID: PMC5413321.
Copy Download .nbib Format: NLM
Corrigendum to "Prostaglandin F.

Neoplasia (New York, N.Y.)

Jiménez-Segovia A, Mota A, Rojo-Sebastián A, Barrocal B, Rynne-Vidal A, García-Bermejo ML, Gómez-Bris R, Hawinkels LJAC, Sandoval P, Garcia-Escudero R, López-Cabrera M, Moreno-Bueno G, Fresno M, Stamatakis K.
PMID: 32304913
Neoplasia. 2020 May;22(5):217-219. doi: 10.1016/j.neo.2020.03.003. Epub 2020 Apr 15.

No abstract available.

Cite
Jiménez-Segovia A, Mota A, Rojo-Sebastián A, et al. Corrigendum to "Prostaglandin F. Neoplasia. 2020;22(5):217-219doi: 10.1016/j.neo.2020.03.003.
Jiménez-Segovia, A., Mota, A., Rojo-Sebastián, A., Barrocal, B., Rynne-Vidal, A., García-Bermejo, M. L., Gómez-Bris, R., Hawinkels, L. J. A. C., Sandoval, P., Garcia-Escudero, R., López-Cabrera, M., Moreno-Bueno, G., Fresno, M., & Stamatakis, K. (2020). Corrigendum to "Prostaglandin F. Neoplasia (New York, N.Y.), 22(5), 217-219. https://doi.org/10.1016/j.neo.2020.03.003
Jiménez-Segovia, Alba, et al. "Corrigendum to "Prostaglandin F." Neoplasia (New York, N.Y.) vol. 22,5 (2020): 217-219. doi: https://doi.org/10.1016/j.neo.2020.03.003
Jiménez-Segovia A, Mota A, Rojo-Sebastián A, Barrocal B, Rynne-Vidal A, García-Bermejo ML, Gómez-Bris R, Hawinkels LJAC, Sandoval P, Garcia-Escudero R, López-Cabrera M, Moreno-Bueno G, Fresno M, Stamatakis K. Corrigendum to "Prostaglandin F. Neoplasia. 2020 May;22(5):217-219. doi: 10.1016/j.neo.2020.03.003. Epub 2020 Apr 15. PMID: 32304913; PMCID: PMC7163295.
Copy Download .nbib Format: NLM
Corrigendum to "Slower Dynamics and Aged Mitochondria in Sporadic Alzheimer's Disease".

Oxidative medicine and cellular longevity

Martín-Maestro P, Gargini R, García E, Perry G, Avila J, García-Escudero V.
PMID: 33510835
Oxid Med Cell Longev. 2021 Jan 14;2021:1643631. doi: 10.1155/2021/1643631. eCollection 2021.

[This corrects the article DOI: 10.1155/2017/9302761.].

Cite
Martín-Maestro P, Gargini R, García E, et al. Corrigendum to "Slower Dynamics and Aged Mitochondria in Sporadic Alzheimer's Disease". Oxid Med Cell Longev. 2021;2021:1643631doi: 10.1155/2021/1643631.
Martín-Maestro, P., Gargini, R., García, E., Perry, G., Avila, J., & García-Escudero, V. (2021). Corrigendum to "Slower Dynamics and Aged Mitochondria in Sporadic Alzheimer's Disease". Oxidative medicine and cellular longevity, 20211643631. https://doi.org/10.1155/2021/1643631
Martín-Maestro, Patricia, et al. "Corrigendum to "Slower Dynamics and Aged Mitochondria in Sporadic Alzheimer's Disease"." Oxidative medicine and cellular longevity vol. 2021 (2021): 1643631. doi: https://doi.org/10.1155/2021/1643631
Martín-Maestro P, Gargini R, García E, Perry G, Avila J, García-Escudero V. Corrigendum to "Slower Dynamics and Aged Mitochondria in Sporadic Alzheimer's Disease". Oxid Med Cell Longev. 2021 Jan 14;2021:1643631. doi: 10.1155/2021/1643631. eCollection 2021. PMID: 33510835; PMCID: PMC7826234.
Copy Download .nbib Format: NLM
Showing 13 to 19 of 19 entries